Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Foster-Milburn was a historical pharmaceutical and patent-medicine company based in Buffalo, New York, with roots in the 19th century and earlier operations in Toronto. The company marketed a range of over-the-counter and proprietary medicines, including Doan's Kidney Pills, Dr. Thomas' Eclectric Oil, Burdock Blood Bitters, and later dermatology and skin-care products such as Keri, Balneol, and Capitrol. By the mid-20th century, Foster-Milburn had developed a notable dermatology-focused business and operated related entities and divisions under the Westwood name. In 1968, its dermatological business was acquired and planned to be operated as Westwood Pharmaceuticals. Foster-Milburn is therefore best understood as a now-defunct historical pharma/consumer-health company rather than a modern biotechnology developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Foster-Milburn.